Published in
American Association for Cancer Research, Cancer Discovery, 6(10), p. 775-778, 2020
DOI: 10.1158/2159-8290.cd-20-0473
Links
Tools
Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19
Journal article published in 2020 by
Sangya Agarwal 
,
Carl H. June
,
Carl H. June
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Abstract Summary: Cytokine release and macrophage activation contribute to immunopathology after SARS-CoV-2 infection. We discuss approaches to decrease the morbidity and mortality in patients with COVID-19 by repurposing existing drugs previously developed for cancer therapy.